Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue European Journal of Medical Genetics Année : 2017

Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses

Ange-Line Bruel
  • Fonction : Auteur
  • PersonId : 994768
Judith St-Onge
  • Fonction : Auteur
  • PersonId : 994653
Thibaud Jouan
  • Fonction : Auteur
  • PersonId : 995276
Paul Kuentz
  • Fonction : Auteur
  • PersonId : 995003
Yannis Duffourd
  • Fonction : Auteur
  • PersonId : 994654

Résumé

BACKGROUND AND OBJECTIVE: Whole-exome sequencing (WES) has now entered medical practice with powerful applications in the diagnosis of rare Mendelian disorders. Although the usefulness and cost-effectiveness of WES have been widely demonstrated, it is essential to reduce the diagnostic turnaround time to make WES a first-line procedure. Since 2011, the automation of laboratory procedures and advances in sequencing chemistry have made it possible to carry out diagnostic whole genome sequencing from the blood sample to molecular diagnosis of suspected genetic disorders within 50 h. Taking advantage of these advances, the main objective of the study was to improve turnaround times for sequencing results. METHODS: WES was proposed to 29 patients with severe undiagnosed disorders with developmental abnormalities and faced with medical situations requiring rapid diagnosis. Each family gave consent. The extracted DNA was sequenced on a NextSeq500 (Illumina) instrument. Data were analyzed following standard procedures. Variants were interpreted using in-house software. Each rare variant affecting protein sequences with clinical relevance was tested for familial segregation. RESULTS: The diagnostic rate was 45% (13/29), with a mean turnaround time of 40 days from reception of the specimen to delivery of results to the referring physician. Besides permitting genetic counseling, the rapid diagnosis for positive families led to two pre-natal diagnoses and two inclusions in clinical trials. CONCLUSIONS: This pilot study demonstrated the feasibility of rapid diagnostic WES in our primary genetics center. It reduced the diagnostic odyssey and helped provide support to families. Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Domaines

Génétique
Fichier non déposé

Dates et versions

hal-01626052 , version 1 (30-10-2017)

Identifiants

Citer

Aurélie Bourchany, Christel Thauvin-Robinet, Daphne Lehalle, Ange-Line Bruel, Paul Masurel-Paulet, et al.. Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses. European Journal of Medical Genetics, 2017, 60 (11), pp.595 - 604. ⟨10.1016/j.ejmg.2017.08.011⟩. ⟨hal-01626052⟩
120 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More